Clinical Trials Sponsored by GeNeuro SA

Total 1185 results

GeNeuro SA

Active, not recruiting

Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19 or PASC Syndrome

Post-COVID-19 Syndrome

Switzerland, Italy, Spain
GeNeuro Innovation SAS

Completed

Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis (ProTEct-MS)

Multiple Sclerosis

Sweden
GeNeuro Innovation SAS

Completed

Safety Study of GNbAC1 in Multiple Sclerosis Patients

Multiple Sclerosis

Switzerland
GeNeuro Innovation SAS

Terminated

A Long-term Extension of Study GNC-401

Multiple Sclerosis

Sweden
GeNeuro Innovation SAS

Completed

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease (LOMBARD)

Multiple Sclerosis (MS) | Clinically Isolated Syndrome (CIS) | Secondary Progressive MS | Primary Progressive MS | Relapsing-Remitting MS

France, Spain, Switzerland
GeNeuro Innovation SAS

Completed

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Normal Population (CONTROL)

Multiple Sclerosis

France
GeNeuro Innovation SAS

Completed

First-in-Human Study With GNbAC1 in Healthy Volunteers

Multiple Sclerosis
GeNeuro Innovation SAS

Completed

Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers

Healthy Volunteers

Germany
GeNeuro Australia PTY Ltd

Completed

Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers

Multiple Sclerosis

Australia
GeNeuro Australia PTY Ltd
Southern Star Research Pty Ltd.

Completed

Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years (RAINBOW-T1D)

Diabetes Mellitus Type 1

Australia
GeNeuro SA
Worldwide Clinical Trials; Institut de Recherches Internationales Servier; Les...

Terminated

Assessing the HERV-W Env ANtagonist GNbAC1 for Evaluation in an Open Label Long-term Safety Study in Patients With Multiple Sclerosis (ANGEL-MS)

Multiple Sclerosis, Relapsing-Remitting

Estonia, Bulgaria, Croatia, Czechia, Germany, Hungary, Italy, Poland, Russian Federation, Serbia, Spain, Ukraine
GeNeuro SA
Worldwide Clinical Trials; Institut de Recherches Internationales Servier; Les...

Completed

Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS (CHANGE-MS)

Multiple Sclerosis, Relapsing-Remitting

Poland, Ukraine, Germany, Spain, Bulgaria, Serbia, Russian Federation, Hungary, Italy, Croatia, Czechia, Estonia
Sankom SA
InterMedService SA; Pharmaxi LLC

Unknown

Study to Evaluate Impact SANKOM Patent Socks in Patients With CVI

Chronic Venous Insufficiency

Ukraine
Teoxane SA

Recruiting

TEOSYAL® PureSense ULTRA DEEP Versus Restylane® Lidocaine for the Correction of Moderate to Severe Nasolabial Folds in Chinese Adults

Nasolabial Folds

China
Aktiia SA

Not yet recruiting

Evaluation of the Satisfaction of a Hypertensive Population in Their Use of the Aktiia 24/7 Blood Pressure Monitor (OBPM_HTN2024)

Hypertension
Aesyra SA

Recruiting

Efficacy of AesyBite Active in Reducing Sleep Bruxism Activity

Sleep Bruxism

Italy
Teoxane SA

Recruiting

Safety and Effectiveness Evaluation of TEOSYAL® TPVM Versus COMPARATOR for the Remodeling of the Lower Face (LIFTUP)

Aging | Chin Retrusion

Switzerland
Stalicla SA

Recruiting

International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder

Autism Spectrum Disorder

United States, Spain, Australia
Distalmotion SA

Recruiting

Robotic MIS With Dexter

Hysterectomy | Partial Nephrectomy | Right Colectomy

Switzerland, France, Germany
Regenosca SA

Recruiting

Bioengineered Collagen Implant for Urethral Stricture Repair

Urethral Stricture

Malaysia
Poxel SA

Not yet recruiting

Study to Assess PXL065 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD)

ALD (Adrenoleukodystrophy)
Sintetica SA

Recruiting

The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population

Hernia, Inguinal | Flat Foot

Italy, Spain
Novigenix SA

Completed

Relapse Markers for Colorectal Cancer (RELMA-C)

Colorectal Cancer

Belgium
Imcyse SA

Active, not recruiting

IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study (IMCY-MS-001)

Multiple Sclerosis, Relapsing-Remitting

Moldova, Republic of
Imcyse SA

Active, not recruiting

In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO

Neuromyelitis Optica

France
LimFlow SA

Active, not recruiting

PROMISE International

Critical Limb Ischemia

New Zealand, Singapore, Netherlands, Germany, Austria
Cardiawave SA

Completed

Valvosoft First-In-Man Study in Severe Symptomatic Aortic Stenosis

Aortic Valve Stenosis

France, Netherlands
Cardiawave SA

Active, not recruiting

Valvosoft First-In-Human Study in Severe Symptomatic Aortic Stenosis

Aortic Valve Stenosis

Serbia
Carmat SA

Suspended

Carmat TAH Early Feasibility Study

End-stage Heart Failure

United States
Mabion SA

Completed

MabionCD20 Compared to MabThera in Lymphoma Patients (MADILYM)

Diffuse Large B-Cell Lymphoma

Serbia, Poland, Croatia, Bosnia and Herzegovina, Georgia, Moldova, Republic of, Ukraine
Teoxane SA

Completed

RHA Redensity - Perioral Rhytids

Aging | Wrinkle | Perioral Rhytids

Canada, United States
Remedee SA

Completed

Migraine STImulation Crisis of Migraine (MISTIC)

Migraine Without Aura

France
Poxel SA

Completed

Study to Assess the Safety, Tolerability, and Pharmacokinetics of PXL770 in Healthy Subjects.

NASH - Nonalcoholic Steatohepatitis

United Kingdom
ObsEva SA

Terminated

A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain

Endometriosis

United States, Canada, Puerto Rico
Imcyse SA

Completed

IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo (IMCY-T1D-002)

Type 1 Diabetes Mellitus

United Kingdom, Belgium, France, Lithuania, Denmark, Germany, Sweden
Aspivix SA

Completed

Usability, Safety and Efficacy of AspivixTM (Comparative Study)

IUD Insertion

Switzerland
Teoxane SA

Completed

RHA® 4 With New Anesthetic - Nasolabial Folds

Pain | Aging

United States
Teoxane SA

Completed

RHA® Redensity With New Anesthetic Agent - Perioral Rhytids

Pain | Aging

United States
Poxel SA

Completed

A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD

Nonalcoholic Fatty Liver

United States
Poxel SA

Completed

A Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLD

Nonalcoholic Fatty Liver

United States
ObsEva SA

Completed

Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids (PRIMROSE 2)

Uterine Fibroids | Heavy Menstrual Bleeding

United States, Bulgaria, Czechia, Hungary, Latvia, Lithuania, Poland, Romania, Ukraine
Poxel SA

Completed

Pharmacokinetics of Imeglimin in Hepatic Impaired Subjects

Hepatic Impairment

Germany
ObsEva SA

Completed

Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function

Renal Impairment | Healthy Participants

United States
ObsEva SA

Completed

Phase 3 Placebo Controlled Study of Nolasiban to Improve Pregnancy Rates in Women Undergoing IVF/ICSI (IMPLANT2)

Infertility

Belgium, Czechia, Denmark, Estonia, Finland, Germany, Hungary, Poland, Spain
PregLem SA

Unknown

Non-interventional Study to Evaluate Long Term Safety, Prescription Management Patterns of Esmya in a Long Term Setting (Premium)

Uterine Fibroids

Spain, Belgium, Denmark, France, United Kingdom, Italy, Czechia, Germany, Romania, Latvia, Hungary, Lithuania, Netherlands, Poland, Portugal, Sweden
Wishbone SA

Unknown

Evaluation of Efficacy and Safety of Wishbone HA as Bone Graft Substitute, a Pre-market Clinical Investigation

Bone Loss in Jaw

Belgium
Poxel SA

Completed

Safety, Tolerability and PK of PXL770 in Healthy Male Subjects

Metabolic Disease

United Kingdom
Him SA

Completed

BeyondSilos - More Personalised and Coordinated Care and Improved Outcomes for Elderly Patients (BeyondSilos)

Heart Failure | Stroke | Diabetes | COPD
Pharnext SA

Completed

Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A

Charcot-Marie-Tooth Disease | Hereditary Neuropathy With Liability to Pressure Palsies | Genetic Disorders

France
Imcyse SA

Terminated

A Trial for Evaluating Both Safety and Preliminary Efficacy of a Single Infusion of Stimulated Autologous CD4+T Cells in Patients With Relapsing- Remitting Multiple Sclerosis (SCLEROLYM)

Multiple Sclerosis, Relapsing-Remitting

Belgium

Clinical Trials Sponsored by GeNeuro SA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations